Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
|
Dec 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
aplastic anemia
|
Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents
|
Dec 2020
|
Leukemia Research
|
myelodysplastic syndromes (MDS)
|
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?
|
Dec 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS)
|
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?
|
Nov 2020
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|
Nov 2020
|
Annals of Oncology: Official Journal of the European Society for Medical Oncology
|
myelodysplastic syndromes (MDS)
|
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients
|
Nov 2020
|
Blood Advances
|
myelodysplastic syndromes (MDS)
|
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease
|
Nov 2020
|
British Journal of Haematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management
|
Nov 2020
|
American Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience
|
Nov 2020
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications
|
Nov 2020
|
Cells
|
myelodysplastic syndromes (MDS)
|